Dr. Scott A. Davis, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Arkansas College of Medicine (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 2,042
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: University of Arkansas College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
AR license C8248
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Health Medical Center-Little Rock Little Rock, AR
- Baptist Health Medical Center North Little Rock North Little Rock, AR
- Baptist Health Medical Center-Stuttgart Stuttgart, AR
- Chambers Memorial Hospital Danville, AR
Medical groups
- Baptist Health (105 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,042
- Services billed
- 7,748
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,176 | 974 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 1,007 | 926 |
| Established patient office or other outpatient visit, 30-39 minutes | 994 | 758 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 687 | 207 |
| Established patient office or other outpatient visit, 40-54 minutes | 405 | 335 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 335 | 115 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 262 | 261 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 257 | 256 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 257 | 256 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 215 | 194 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Tartrate Other prescribers in Little Rock, AR | 559 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Little Rock, AR | 431 |
| Eliquis (apixaban) Other prescribers in Little Rock, AR | 415 |
| Atorvastatin Calcium Other prescribers in Little Rock, AR | 413 |
| Furosemide Other prescribers in Little Rock, AR | 385 |
| Amlodipine Besylate Other prescribers in Little Rock, AR | 338 |
| Losartan Potassium Other prescribers in Little Rock, AR | 321 |
| Carvedilol Other prescribers in Little Rock, AR | 290 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Little Rock, AR | 273 |
| Ranolazine Er (ranolazine) Other prescribers in Little Rock, AR | 228 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 13 payments worth $409 in total to this clinician.
| Angiodynamics, Inc. | $188 |
|---|---|
| Novartis Pharmaceuticals Corporation | $82.37 |
| E.r. Squibb & Sons, L.l.c. | $32.75 |
| Heartflow, Inc. | $24.53 |
| Abbott Laboratories | $24.37 |
| GE Healthcare | $22.01 |
| Atricure, Inc. | $18.17 |
| Cardiva Medical, Inc. | $17.48 |
| Food and Beverage | $409 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $15,129 in research payments for these studies, mostly to the institutions running them.
- A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and…
AstraZeneca Pharmaceuticals LP - This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the efficacy and safety of AZD4831 administered for up to 48 Weeks in participants with heart failure…
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.